These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2548961)

  • 41. Does insulin release kinins in rats?
    Damas J; Garbacki N; Lefèbvre PJ
    Eur J Pharmacol; 2005 Nov; 525(1-3):154-60. PubMed ID: 16297383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. D-Arg
    Bachelard H; Charest-Morin X; Marceau F
    Front Pharmacol; 2018; 9():273. PubMed ID: 29636689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
    Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
    Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
    Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
    Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway.
    Nowak W; Errasti AE; Armesto AR; Santín Velazque NL; Rothlin RP
    Eur J Pharmacol; 2011 Sep; 667(1-3):271-7. PubMed ID: 21651905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin.
    Pham I; Gonzalez W; Doucet J; Fournie-Zaluski MC; Roques BP; Michel JB
    Eur J Pharmacol; 1996 Feb; 296(3):267-76. PubMed ID: 8904078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathways of bradykinin degradation in blood and plasma of normotensive and hypertensive rats.
    Dendorfer A; Wolfrum S; Wagemann M; Qadri F; Dominiak P
    Am J Physiol Heart Circ Physiol; 2001 May; 280(5):H2182-8. PubMed ID: 11299220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of kinins on mammalian spermatozoa and the impact of peptidolytic enzymes.
    Siems WE; Maul B; Wiesner B; Becker M; Walther T; Rothe L; Winkler A
    Andrologia; 2003 Feb; 35(1):44-54. PubMed ID: 12558528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bradykinin metabolism in the postinfarcted rat heart: role of ACE and neutral endopeptidase 24.11.
    Raut R; Rouleau JL; Blais C; Gosselin H; Molinaro G; Sirois MG; Lepage Y; Crine P; Adam A
    Am J Physiol; 1999 May; 276(5):H1769-79. PubMed ID: 10330262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats.
    Stanziola L; Greene LJ; Santos RA
    Am J Hypertens; 1999 Oct; 12(10 Pt 1):1021-9. PubMed ID: 10560789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of pH on the inhibition of angiotensin converting activity by enalaprilat in the rat perfused mesenteric vascular bed.
    Lindsey CJ; Bendhack LM; Paiva AC
    J Pharmacol Exp Ther; 1987 Oct; 243(1):292-6. PubMed ID: 2822902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats.
    Lima CV; Paula RD; Resende FL; Khosla MC; Santos RA
    Hypertension; 1997 Sep; 30(3 Pt 2):542-8. PubMed ID: 9322979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
    Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinin-related effects of angiotensin-converting enzyme inhibition.
    Bönner G
    Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret trachea.
    Dusser DJ; Nadel JA; Sekizawa K; Graf PD; Borson DB
    J Pharmacol Exp Ther; 1988 Feb; 244(2):531-6. PubMed ID: 3279179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism of bradykinin by peptidases in the lung.
    Dragović T; Igić R; Erdös EG; Rabito SF
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1491-6. PubMed ID: 8389109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma kinin levels in acute renovascular hypertension in dogs.
    Moore J; Gagnon JA; Verma PS; Sander GE; Butkus DE
    Ren Physiol; 1984; 7(2):102-14. PubMed ID: 6200903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of T-kinin on microvascular permeability and its modulation by peptidases in rat airways.
    Yamawaki I; Tamaoki J; Takeda Y; Chiyotani A; Sakai N; Kameyama S; Konno K
    J Appl Physiol (1985); 1995 Oct; 79(4):1129-33. PubMed ID: 8567553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue.
    Campbell DJ; Duncan AM; Kladis A
    Hypertension; 1999 Aug; 34(2):171-5. PubMed ID: 10454436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lung peptidases, including carboxypeptidase, modulate airway reactivity to intravenous bradykinin.
    Chodimella V; Skidgel RA; Krowiak EJ; Murlas CG
    Am Rev Respir Dis; 1991 Oct; 144(4):869-74. PubMed ID: 1928964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.